Allogenic mesenchymal stromal cell therapy (UMC Utrecht)

异基因间充质干细胞疗法（乌德勒支大学医学中心）

Report date: 2023/01/12 15:28:52

Base Information

Drug NameAllogenic mesenchymal stromal cell therapy (UMC Utrecht)

Drug Alias NameBM-MSC

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsUlcerScleroderma, Systemic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversitair Medisch Centrum Utrecht

China Registration ClassN/A

Develop Information

Active CompaniesUniversitair Medisch Centrum Utrecht

Inactive CompaniesN/A

Active IndicationsUlcerScleroderma, Systemic

Inactive IndicationsN/A

Other Information

ATC CodeN/A